Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Monocytic, Acute × tipifarnib × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pheochromocytoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Central Nervous System Neoplasms 1

Interventions

Cytarabine 5 Whole-Body Irradiation 3 Peripheral Blood Stem Cell Transplantation 3 Injections 3 Biopsy 3 Azacitidine 3 venetoclax 2 pegylated granulocyte colony-stimulating factor 2 Tacrolimus 2 Sirolimus 2 Idarubicin 2 Gemtuzumab 2 Decitabine 2 Daunorubicin 2 Cyclophosphamide 2 Cladribine 2 Busulfan 2 Bone Marrow Transplantation 2 ruxolitinib 1 fludarabine phosphate 1 fludarabine 1 fedratinib 1 aldesleukin 1 Thiotepa 1 Spinal Puncture 1 Specimen Handling 1 Social Determinants of Health 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1 Mitoxantrone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡